New program aims to transform diabetes treatment in nigeria
NCT ID NCT07589387
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study will test a program based on WHO guidelines to improve diabetes screening and care in 10 primary health centers in Nigeria. About 2,800 adults with or at risk for diabetes will take part. The goal is to see if the program helps more people get diagnosed and treated.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Implementation of WHO HEARTS-D guidelines (a care program, not a drug)
- What this could lead to
- If successful, this could show a practical way to improve diabetes diagnosis and management in low-resource settings.
- What could go wrong
- This is an implementation study, not a test of a new treatment. Results may not apply to other regions or populations.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETE MELLITUS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Antioxidant-rich diets may fight inflammation in type 2 diabetes — a study investigates
- Fig leaf tea may shield kidneys from diabetes damage — a trial puts it to the test
- Could vinegar and fasting fix prediabetes cholesterol?
- Diabetes drug shows promise for repairing damaged nerves
- Foot flex could tame cholesterol and blood sugar
- Mass screening aims to catch silent killers early in pakistan